Contemporary Diagnosis of Heart Failure: Integrating Traditional Tools and Emerging Biomarkers
International Journal of Angiology · 2026-12 · 35 (04) · 270-279
DOI: 10.1055/a-2846-3245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Angiology, online erschienen am 08.04.2026. Verfasst von Jasneet Kaur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Nassau University Medical Center, East Meadow, New YorkUnited States. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) is a diverse clinical syndrome resulting from structural or functional cardiac abnormalities, leading to impaired cardiac output and increased filling pressures. Early and accurate diagnosis is crucial to guide therapy, improve prognosis, and reduce morbidity and mortality. This review outlines a contemporary stepwise diagnostic framework that reflects a real-world approach, integrating clinical evaluation, laboratory testing, imaging, and hemodynamic assessment. Particular emphasis is placed on biomarkers, including B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP), and echocardiography, which remain the backbone of HF diagnosis, while advanced imaging, genetic testing, and cardiopulmonary exercise testing are used to resolve diagnostic uncertainty in select complex cases. Rather than treating HF as a single entity, this review highlights specific etiologies, including ischemic, genetic, inflammatory, infiltrative, endocrine, and arrhythmogenic causes, and their specific diagnostic considerations. Novel biomarkers, implanted pressure monitoring, and artificial intelligence are examples of emerging techniques that are beginning to complement traditional testing and offer opportunities for early detection, individualized treatment, and preventive measures. By combining traditional and innovative diagnostic tools, clinicians can identify HF promptly, tailor therapy to underlying causes, and ultimately improve patient outcomes and quality of life.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Nassau University Medical Center, East Meadow, New YorkUnited States.
- Department of Cardiology, Nassau University Medical Center, East Meadow, New YorkUnited States.
- Department of Cardiology, Cardiovascular Institute, Northwell Health, New Hyde Park, New YorkUnited States.
- Department of Cardiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New YorkUnited States.
ORCID-Profile: Jasneet Kaur, Amgad N Makaryus
Zitieren
APA
Kaur, J., Staroselsky, M., Berman, L., Kelschenbach, K., Oprysko, C., Materia, A., Makaryus, A. N., & Zeltser, R. (2026). Contemporary Diagnosis of Heart Failure: Integrating Traditional Tools and Emerging Biomarkers. International Journal of Angiology, 35(04), 270-279. https://doi.org/10.1055/a-2846-3245
Vancouver
Kaur J, Staroselsky M, Berman L, Kelschenbach K, Oprysko C, Materia A, et al. Contemporary Diagnosis of Heart Failure: Integrating Traditional Tools and Emerging Biomarkers. International Journal of Angiology. 2026;35(04):270-279. doi:10.1055/a-2846-3245
BibTeX
@article{Kaur2026,
author = {Kaur, Jasneet and Staroselsky, Mark and Berman, Lorin and Kelschenbach, Kyle and Oprysko, Carson and Materia, Angelo and Makaryus, Amgad N and Zeltser, Roman},
title = {Contemporary Diagnosis of Heart Failure: Integrating Traditional Tools and Emerging Biomarkers},
journal = {International Journal of Angiology},
year = {2026},
volume = {35},
number = {04},
pages = {270--279},
doi = {10.1055/a-2846-3245}
}
EUVIMED